Skip to Main Content

INFORMATION FOR

    Michaela Dinan, PhD

    Professor of Epidemiology (Chronic Diseases)
    DownloadHi-Res Photo

    Additional Titles

    Associate Cancer Center Director for Research Training and Education, Yale Cancer Center

    Co-Director, Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine

    Co-Leader, Cancer Prevention and Control, Yale Cancer Center

    About

    Titles

    Professor of Epidemiology (Chronic Diseases)

    Associate Cancer Center Director for Research Training and Education, Yale Cancer Center; Co-Director, Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine; Co-Leader, Cancer Prevention and Control, Yale Cancer Center

    Biography

    Dr. Michaela Dinan is a Professor of Epidemiology in the Yale School of Public Health, Associate Cancer Center Director for Cancer Research Training and Education at the Yale Cancer Center (YCC) as well as Co-Director of the Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center. She is also co-leader of the YCC Cancer Prevention and Control Research Program. Dr. Dinan has extensive research expertise in leveraging existing real-world data sources as well as novel data linkages to examine oncology outcomes.

    Dr. Dinan is a health services researcher by training and she specializes in using econometric and epidemiologic methodologies to analyze complex datasets. Specifically, Dr. Dinan's research examines advances in cancer care technologies, such as emerging treatments and diagnostics, and how these advances in technologies impact different cancer outcomes and experiences such as access, quality of care, cost of care, and health disparities.

    Dr. Dinan has led studies funded by the National Institutes of Health, the American Cancer Society, and the Agency for Healthcare Research and Quality. She is currently MPI of an NCI-funded R01 study examining broad genomic profiling in patients with lung cancer to determine how testing and test results impact treatment, survival, and costs of care. Dr. Dinan is also leading a study funded by the ACS to develop and validate risk prediction algorithms to inform efficient and high-quality care for long-term cancer survivors.

    In 2021, Dr. Dinan led the first linkage of the Medicare claims data to physical tumor specimens and cancer registry data. This proof-of-concept study was the first to demonstrate the ability to combine the detailed clinicopathologic data from the SEER Registry, the longitudinal follow-up provided by the Medicare claims data, with genomic sequence data obtained from the physical tumor specimen all into one dataset. Dr. Dinan is the PI of an ACS Research Scholar Grant building on this novel data linkage to determine the molecular etiology of aggressive screening-detected breast cancers.

    Last Updated on October 05, 2025.

    Appointments

    Other Departments & Organizations

    Education & Training

    PhD
    University of North Carolina, Health Policy and Management (2011)

    Research

    Overview

    Dr. Dinan has extensive research expertise in leveraging existing real-world data sources as well as novel data linkages to examine oncology outcomes. She is a health services researcher with training in econometric and epidemiologic methodologies to analyze complex datasets. Specifically, Dr. Dinan's research involves issues related to access and quality of care, health disparities, and cost of care for cancer patients.



    Medical Research Interests

    Breast Neoplasms; Cancer Survivors; Carcinoma, Renal Cell; Chronic Disease; Colonic Neoplasms; Costs and Cost Analysis; Epidemiology; Risk Assessment; Urologic Neoplasms

    Public Health Interests

    Aging; Cancer; Chronic Diseases; Health Equity, Disparities, Social Determinants and Justice; Health Policy; Pharmacoepidemiology; Women's Health

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of Michaela Dinan's published research.

    Publications

    2025

    Get In Touch

    Contacts

    Academic Office Number
    Mailing Address

    Chronic Disease Epidemiology

    PO Box 208034, 60 College St

    New Haven, CT 06520

    United States

    Locations

    • Ste 444

      Academic Office

      60 College Street

      New Haven, CT 06510